SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-085873
Filing Date
2024-07-24
Accepted
2024-07-24 09:23:48
Documents
96
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20240630.htm   iXBRL 10-Q 2601898
2 EX-10.1 alks-ex10_1.htm EX-10.1 32433
3 EX-10.2A alks-ex10_2a.htm EX-10.2A 29269
4 EX-10.2B alks-ex10_2b.htm EX-10.2B 29963
5 EX-31.1 alks-ex31_1.htm EX-31.1 16633
6 EX-31.2 alks-ex31_2.htm EX-31.2 16648
7 EX-32.1 alks-ex32_1.htm EX-32.1 19207
8 GRAPHIC img77520285_0.jpg GRAPHIC 4907
9 GRAPHIC img77520285_1.jpg GRAPHIC 134869
10 GRAPHIC img77520285_2.jpg GRAPHIC 43283
11 GRAPHIC img77520285_3.jpg GRAPHIC 21082
  Complete submission text file 0000950170-24-085873.txt   11533384

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20240630.xsd EX-101.SCH 1467050
99 EXTRACTED XBRL INSTANCE DOCUMENT alks-20240630_htm.xml XML 2159863
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 241136423
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)